Princeton, NJ, January 9, 2020. Indegene, a global healthcare technology leader dedicated to transforming the life sciences industry, has announced that Syneos Health (NASDAQ: SYNH) has become a strategic investor in its subsidiary, Exeevo. Syneos Health, is renowned for its fully integrated biopharmaceutical solutions, delivers comprehensive drug development and commercialization services to biopharmaceutical companies across more than 110 countries
Exeevo is a next-generation unified customer experience platform designed specifically for life sciences organizations. It integrates CRM, marketing automation, medical, event management, service, customer insights, and more into a single, seamless solution. This platform empowers sales, marketing, medical, and operations teams to deliver a 360-degree omnichannel engagement experience, enhanced by advanced analytics and AI capabilities.
Built as part of a strategic alliance with Microsoft in 2017, the Exeevo CRM platform leverages Microsoft Azure, Power Platform for business applications, and seamless interoperability with Microsoft Office 365 and Teams for enhanced productivity and collaboration. With Indegene’s deep industry expertise, analytics, and omnichannel engagement IP, Exeevo enables life sciences organizations to elevate and transform customer engagement experiences for their customers and business stakeholders.
“We are excited to welcome Syneos Health as an investor for Indegene’s Exeevo subsidiary. This investment will further accelerate the roadmap and deployments of our CRM that provides a best in class customer engagement platform for life sciences clients. Our Exeevo solution truly applies the power of modern omnichannel technology and advanced capabilities such as machine learning to achieve best-in-class customer-centric experiences”, said Manish Gupta, co-founder, and CEO of Indegene.
Dr. Rajesh Nair, co-founder and President, Indegene added, “Both Indegene and Syneos Health are experienced in life sciences clinical development, commercialization and global enterprise scale engagements. With this investment, Indegene Omnipresence will significantly strengthen its position as the next-generation Customer Experience Management platform through expanded global resources and expertise, providing a much-needed option to meet the dramatically changing needs of the industry.”
Alistair Macdonald, CEO, Syneos Health commented, “We’re excited to partner with Omnipresence the innovative platform, underpinned by Microsoft technologies, to address customer demand to drive high-value commercial relationships in an increasingly competitive marketplace. Syneos Health’s Dynamic Assembly network is an open ecosystem of the most agile data and technology collaborators, such as Omnipresence, to strategically address our biopharmaceutical customers’ challenges.”
“Omnipresence is a good example of an industry-specific, multi-cloud solution built with Microsoft’s enterprise technologies working together in uniquely disruptive ways. We are excited to see Indegene add Syneos Health as another strategic collaborator in our joint mission to bring new value to life sciences and healthcare organizations,” said James Phillips, Corporate Vice President, Business Applications Group, Microsoft.
For more information about how the Exeevo CRM platform can transform your life sciences organization’s customer engagement to drive growth, visit www.exeevo.com or contact our team at sales@exeevo.com.
About Syneos Health
Syneos Health® is a leading integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
About Indegene
Indegene Limited (BSE: 544172, NSE: INDGN) is a digital-first, life sciences commercialization company. It helps biopharmaceutical, emerging biotech, and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. Indegene brings together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable, and omnichannel experience for patients and physicians. It’s what drives Indegene’s team and their purpose to enable healthcare organizations to be future-ready.
About Exeevo
Exeevo, a subsidiary of Indegene Limited (BSE: 544172, NSE: INDGN), is a leader in CRM solutions for life sciences organizations. We empower pharmaceutical, emerging biotech, and medical device companies to deliver exceptional, personalized experiences across every customer journey stage. With a deep understanding of the life sciences landscape, Exeevo combines Microsoft’s innovative technology, Indegene’s industry expertise, and a leadership with an agile approach to deliver outcomes that matter. From scalable omnichannel engagement to insights-driven marketing and customer service, our offerings are designed to enhance collaboration, drive efficiency, and ensure that life sciences organizations are equipped for the future.
Press/Media Contact:
Cynthia Ruffino, AVP Marketing
###